July 2026 in “Vestnik dermatologii i venerologii” Among women with androgenetic alopecia, this study observed that using Jet Peel™ with JetCare® serum led to significant trichoscopic changes, high satisfaction, and good safety after five weeks, suggesting it as a viable additional treatment option.
July 2026 in “Vestnik dermatologii i venerologii” This study found that a serum with a minoxidil derivative and high-concentration niacinamide was effective in improving androgenetic alopecia in women, with 65.8% showing clinical recovery after 4 months, and reported good tolerability and increased treatment compliance.
June 2026 in “Vestnik dermatologii i venerologii” This study evaluated the use of Jet Peel technology, a non-invasive hydroporation method, in treating androgenetic and telogen effluvium alopecia, finding improvements in hair growth and thickness, and a reduction in associated scalp conditions.
January 2026 in “Vestnik dermatologii i venerologii” This review found that AI in dermatology shows high diagnostic accuracy comparable to experienced clinicians, but integration into clinical practice faces challenges requiring further research.
January 2026 in “Vestnik dermatologii i venerologii” In this review, the authors report that tacrolimus ointment shows promise for expanding its use to a variety of skin conditions, beyond its current approval for atopic dermatitis, by analyzing clinical experiences of its application for rosacea, seborrheic dermatitis, psoriasis, and other dermatoses.
August 2025 in “Vestnik dermatologii i venerologii” In this article, the authors concluded that despite diverse causes of diffuse hair loss, modern therapies can effectively manage the condition without side effects, as demonstrated in two clinical cases of telogen effluvium.
April 2025 in “Vestnik dermatologii i venerologii” This study demonstrated the high effectiveness and safety of tofacitinib, a pan-JAK inhibitor, in treating severe forms of alopecia areata, although it is not yet FDA-approved for this condition.
February 2025 in “Vestnik dermatologii i venerologii” This case report describes a 47-year-old patient with scarred alopecia diagnosed as discoid lupus erythematosus, where treatment with multiple medications led to clinical improvement.
July 2024 in “Vestnik dermatologii i venerologii” This study found that women with post-COVID alopecia showed a diffuse telogen effluvium pattern and distinct trace element imbalances, such as reduced copper and increased selenium levels, helping differentiate this condition from androgenetic alopecia.
April 2024 in “Vestnik dermatologii i venerologii” This review highlights the diagnostic potential and therapeutic prospects of exosomes, discussing their use in managing chronic immune-mediated skin conditions, alopecia, and wound healing through their capacity to deliver regulatory molecules between cells.
May 2023 in “Vestnik dermatologii i venerologii” In this study, researchers examined men with early-stage androgenetic alopecia and found distinct patterns of hair loss correlated with genetic and hormonal factors, noting that parietal region pattern hair loss responded better to minoxidil and micronutrient treatment compared to occipital region pattern.
December 2020 in “Vestnik dermatologii i venerologii” This study found that combining iron supplements with physiotherapy resulted in improved hair growth and condition in women with telogen alopecia and mild iron deficiency anemia.
December 2020 in “Vestnik dermatologii i venerologii” This study found that combining iron supplements with physiotherapy improved hair condition and growth in women with iron deficiency-related telogen hair loss compared to iron supplements alone.
June 2013 in “Vestnik dermatologii i venerologii” This study found that women with androgenic alopecia often have increased dihydrotestosterone levels, suggesting potentially enhanced activity of 5-alpha-reductase, with the saliva free testosterone level providing valuable hormonal background information.
April 2011 in “Vestnik dermatologii i venerologii” This study found an association between 'short' CAG repeats in the androgen receptor gene and increased non-random X chromosome inactivation in women with androgenic alopecia.
February 2011 in “Vestnik dermatologii i venerologii” This study observed a decrease in hair density and average hair diameter, along with an increase in hair loss, among females with androgenic alopecia compared to healthy controls.
December 2010 in “Vestnik dermatologii i venerologii” This article reviews molecular and genetic mechanisms in the development of androgenic alopecia and examines the relationship between androgen receptor gene polymorphism and androgen-dependent diseases, but reports no new clinical results.
8 citations
,
November 2012 in “Journal of Endocrinological Investigation” This study found that Greek women with classic PCOS phenotypes have a higher risk of metabolic syndrome and impaired glucose homeostasis compared to those with newer PCOS phenotypes.
1 citations
,
September 2001 in “PubMed” Phenytoin, a medication, can cause hair loss and trigger a condition similar to lupus.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers evaluated hair loss in 40 participants and identified key Ayurvedic and biochemical factors, finding frequent dietary incompatibilities and a high prevalence of low serum calcium, supporting an integrated approach emphasizing diet and scalp health.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that many participants with hair loss, or Khalitya, exhibited dietary incompatibilities and low calcium levels, aligning Ayurvedic concepts with modern dietary risk factors.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, low serum calcium and dietary incompatibilities were linked to hair loss, supporting Ayurveda's connection between Asthi Dhatu and hair, and suggesting an integrative approach for prevention.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this observational study, researchers found that 55% of participants with hair loss known as Khalitya had serum calcium deficiency, which aligns with both Ayurvedic and modern perspectives linking poor nutrition to hair disorder, highlighting the importance of dietary regulation and stress management.
This review discusses the potential benefits of Ayurvedic remedies—Withania somnifera, Emblica officinalis, Eclipta alba, and Glycyrrhiza glabra—in treating alopecia, highlighting their mechanisms such as inhibiting 5α-reductase, enhancing blood flow, and modulating hair growth pathways, while noting their advantages like fewer side effects and cost-effectiveness.
2 citations
,
December 2024 in “International Journal of Molecular Sciences” This study found that mesenchymal stem cells from chronically inflamed human livers maintain their key cellular characteristics, supporting their potential use in developing liver cell therapies.
2 citations
,
April 2021 in “Reproductive health of woman” This study found that among women with PCOS, the most common clinical symptoms were menstrual dysfunction, infertility, acne, and hirsutism, with the non-androgenic phenotype being the most frequently identified.
1 citations
,
July 2023 in “Cancers” In this multicentric retrospective study, researchers reported that cutaneous adverse events were common among advanced breast cancer patients treated with cyclin-dependent kinase inhibitors (CDK4/6i), generally mild, and manageable with topical treatments, though in some cases, they led to treatment discontinuation.
October 2024 in “Российский физиологический журнал им И М Сеченова” This study explores the neurobiology and genetics of barbering (hair and whisker biting) in laboratory rodents, and its potential links to stress, aggression, grooming, and stereotypic behaviors, highlighting its significance in experimental work with these animals.
January 2024 in “Wiadomości Lekarskie” This study found that using Lactobacillus reuteri DSM 17938 probiotics significantly improved IBS symptoms in children, with optimal therapy duration suggested to be 1-3 months based on symptom and calprotectin level reductions.
February 2023 in “Sibirskij onkologičeskij žurnal” In this review, chemotherapy-induced alopecia in cancer patients is linked to drug pharmacology, genetics, and nutrition, affecting patients' mental health; scalp cooling is highlighted as an effective prevention method, but more research is needed for broader solutions.